ESLA — Estrella Immunopharma, Inc. Dilution Risk Tracker

Estrella Immunopharma, Inc. (ESLA) carries a DilutionScore of 84/100, placing it in the Critical dilution risk tier — the highest category tracked by DilutionWatch. Companies at this level typically have active capital-raising programs, compressed cash runway, or a combination of dilution vectors that together represent meaningful downside risk to share count. As of July 14, 2026, this score reflects real-time data pulled directly from SEC EDGAR filings.

Cash runway is a key watch item: ESLA has approximately 1 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for ESLA in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for ESLA alongside comparable critical-risk stocks. Not financial advice — this analysis is for informational purposes only.